White paper: Streamlining Pharma Operations in the Wake of COVID-19

Published: 13-Oct-2020
Regulatory

COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris

NSF's white paper from Jim Morris discusses the importance of streamlining pharma operations in a COVID-19 environment.

He highlights the vital areas that will warrant leadership attention including supplier oversight, inspection readiness and the impact on personnel.

Click here to download the white paper.

  • Companies:
  • NSF
See more

You may also like

Regulatory

NSF International launches two water fitting accreditations

Read more
New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market

Trending Articles

  1. Certa Therapeutics' GPR68 inhibitor FT011 granted EU Orphan Designation for systemic sclerosis The G-protein coupled receptor (GPCR) targeting therapeutic could work to prevent scarring caused by systemic sclerosis
  2. European Pharmacopoeia removes rabbit pyrogen test from its repertoire The development will require medicine developers to use in vitro testing instead of RPT to determine the pyrogen levels in its injectables
  3. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  4. Animal testing still being 'unnecessarily' utilised by a majority of R&D organisations, survey reveals Although there are in vitro alternatives that could more accurately predict human therapeutic responses, a majority of R&D companies still use animal testing
  5. Innopharma Technology Headquartered in Dublin, Ireland, we design and develop Industry 5.0 manufacturing solutions that simplify process intelligence by delivering data in real-time. Our solutions enable quick decision-making, reduce time-to-market, and support better outcomes. By offering insight, process control, and intelligence, we offer manufacturers and researchers the tools to fully embrace the benefits of Industry 5.0. From the Industrial Internet of Things (IIoT) to automation solutions, we can guide your journey to smart manufacturing with Eyecon 2 , Multieye 2 , and SmartX.

Upcoming event

ISPE Singapore

28-30 August 2024 | Conference and exhibition | Singapore See all

You may also like

Regulatory

NSF International launches two water fitting accreditations

New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market
Regulatory

2022 Pharma Training Courses from NSF

Start your year right and keep your goals on track with NSF’s training and education. NSF's pharma training and education programs focus on changing behaviours at both an individual and organisation-wide level
Regulatory

NSF explains why you might need a remediation program

The team at NSF explores why remediation projects are needed, the traits of successful programs and what to do to ensure success in your remediation efforts
Regulatory

Pharmaceutical legislation update subscription service

Sign up for NSF’s September start date
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Regulatory

Free webinar: Update on EMA and FDA’s approach to tackling drug shortages

The webinar will be hosted on 8 September, 2020 – 1pm BST
Regulatory

New edition of NSF’s Health Sciences Journal now live

The new Health Sciences Journal focuses on hope and optimism and is available to download
Subscribe now